Search
Now showing items 1-10 of 14
Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia
(Wiley, 2021)
Background Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Data on risk factors, treatment options, and outcomes are ...
Comparison of turkish stem cell coordination center (TURKOK) with Istanbul University bone marrow bank (TRIS); a single center experience in match unrelated donors
(Nature Publishing Group, 2019)
[No abstract available]
Stem cell transplantation for high-risk acute lymphoblastic leukemia in a developing country: A single-center experience
(Wiley, 2020)
[No abstract available]
Donor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience
(Nature Publishing Group, 2019)
Allogeneic stem cell transplantation (allo-SCT) is considered the cornerstone in the treatment of several malignant and not malignant hematological diseases. However, relapse of hematological disease after allo-SCT is ...
Immune reconstitution of thalassemia major patients after 1 year of hematopoetic stem cell transplantation
(Nature Publishing Group, 2019)
Immune reconstitution inflammatory syndrome (IRIS) is a clinical condition emerging after immune recovery of an immunocompromised status, mostly in human immunodeficiency virus infected patients but also in several other ...
Extracorporeal photopheresis treatment for steroid resistant graft versus host disease in pediatrics: Single center experience
(Nature Publishing Group, 2019)
[No abstract available]
COVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study
(Wiley, 2021)
Adults with cancer are reported to have a higher risk for coronavirus disease (COVID-19) infection and more severe disease and mortality than the general population.1,2 Although children seem to be at a lower risk for ...
Comparison of hematopoietic stem cell transplantation results in patients with beta-thalassemia major from three different graft types
(Taylor & Francis Ltd, 2021)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the curative therapy for beta-thalassemias that induces severe life-threatening complications. The human leukocyte antigen (HLA) registries and umbilical cord ...
Busulfan–fudarabine‑ or treosulfan–fudarabine‑based myeloablative conditioning for children with thalassemia major
(Annals of Hematology, 2021)
Signifcant advances in supportive care for patients with transfusion-dependent thalassemia major (TDT) have improved
patients’ life expectancy. However, transfusion-associated iron overload remains a signifcant barrier ...
Evaluation of the risk factors for BK virus-associated hemorrhagic cystitis in pediatric bone marrow transplantation patients: Does post-transplantation cyclophosphamide increase the frequency?
(2022)
Background: BKV-HC is one of the most significant complications of HSCT. This ret -rospective study aimed to determine the frequency of BKV-HC in pediatric patients undergoing HSCT, detect the ...
